Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
175
NCT01879163
Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults
Phase: Phase 1
Role: Collaborator
Start: Jul 31, 2013
Completion: Dec 31, 2014
NCT03497572
Seroprevalence Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept® Vaccine
Phase: N/A
Role: Lead Sponsor
Start: Aug 25, 2017
Completion: Apr 12, 2018